For pulmonary fibrosis, dry powder inhalers containing luteolin (LUT@CDMOF) downregulated TGF-β1/Smad3 and attenuated bleomycin-induced interstitial lesions (Ren et al., 2023). Here, TGFB1 is linked to pulmonary fibrosis.